🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide MASH Phase 2b — March 2026 Page 3

Survodutide MASH Phase 2b — March 2026

CanadaChris Fri, Aug 15, 2025 at 9:27 PM 31 replies 1,956 viewsPage 3 of 7
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Aug 16, 2025 at 4:05 PM#11
BariatricNurseD said:
It helps to say which part of this you are uncertain about.

No disagreement with BariatricNurseD. One condition attached. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

25 23TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 22 others
Reply Quote Save Share Report
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Aug 17, 2025 at 1:18 AM#12
NurseKim_ATL said:
Agreed, and ALT falling is not the same as fibrosis improving.

This is exactly what I could not find anywhere else.

Last edited: Aug 17, 2025 at 3:18 AM
26 24Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 23 others
Reply Quote Save Share Report
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Aug 17, 2025 at 10:31 AM#13
BariatricNurseD said:
It helps to say which part of this you are uncertain about.

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

That is the short version; the long version is somebody else's post.

27 0Dr.GutHealth, amsterdam_pete, LondonLisa and 24 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Aug 17, 2025 at 7:44 PM#14

Adding the numbers, since they settle part of this. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

That is the short version; the long version is somebody else's post.

28 1JessicaM_2024, TomFromTexas, mike.trainer_LA and 25 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Aug 18, 2025 at 4:57 AM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Report rather than reply if it drifts again.

Last edited: Aug 18, 2025 at 6:57 AM
29 2PurityPaulOR, MaxMetOK, MounjBrad and 26 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register